These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 25486910)

  • 41. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.
    Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF
    Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long‑term exposure to gefitinib induces acquired resistance through DNA methylation changes in the EGFR‑mutant PC9 lung cancer cell line.
    Terai H; Soejima K; Yasuda H; Sato T; Naoki K; Ikemura S; Arai D; Ohgino K; Ishioka K; Hamamoto J; Kanai Y; Betsuyaku T
    Int J Oncol; 2015 Jan; 46(1):430-6. PubMed ID: 25353970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A microRNA signature of response to erlotinib is descriptive of TGFβ behaviour in NSCLC.
    Krentz Gober M; Collard JP; Thompson K; Black EP
    Sci Rep; 2017 Jun; 7(1):4202. PubMed ID: 28646226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features.
    Kim DS; Kim MJ; Lee JY; Lee SM; Choi JE; Lee SY; Park JY
    Lung Cancer; 2009 Aug; 65(2):247-50. PubMed ID: 19362748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whole DNA methylome profiling in lung cancer cells before and after epithelial-to-mesenchymal transition.
    Liu F; Zhou Y; Zhou D; Kan M; Niu X; Zhang Z; Zhang D; Tao L; He L; Zhan L; Liu Y
    Diagn Pathol; 2014 Mar; 9():66. PubMed ID: 24655585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study of the methylation patterns of the EGFR gene promoter in non-small cell lung cancer.
    Pan ZY; Jiang ZS; Ouyang HQ
    Genet Mol Res; 2015 Aug; 14(3):9813-20. PubMed ID: 26345914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetic Suppression of the T-box Subfamily 2 (
    Nehme E; Rahal Z; Sinjab A; Khalil A; Chami H; Nemer G; Kadara H
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A phase II study of erlotinib monotherapy in pre-treated non-small cell lung cancer without EGFR gene mutation who have never/light smoking history: re-evaluation of EGFR gene status (NEJ006/TCOG0903).
    Matsumoto Y; Maemondo M; Ishii Y; Okudera K; Demura Y; Takamura K; Kobayashi K; Morikawa N; Gemma A; Ishimoto O; Usui K; Harada M; Miura S; Fujita Y; Sato I; Saijo Y;
    Lung Cancer; 2014 Nov; 86(2):195-200. PubMed ID: 25249428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα.
    Dopeso H; Jiao HK; Cuesta AM; Henze AT; Jurida L; Kracht M; Acker-Palmer A; Garvalov BK; Acker T
    Cancer Res; 2018 Apr; 78(7):1805-1819. PubMed ID: 29339541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
    Zhang Y; Miao Y; Yi J; Wang R; Chen L
    Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Statistical and bioinformatic analysis of hemimethylation patterns in non-small cell lung cancer.
    Sun S; Zane A; Fulton C; Philipoom J
    BMC Cancer; 2021 Mar; 21(1):268. PubMed ID: 33711952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers].
    Wei WL; Hu HY; Zhang LJ; Chen Y; Ye E; Wang XF
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):532-6. PubMed ID: 22169642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A seven-gene CpG-island methylation panel predicts breast cancer progression.
    Li Y; Melnikov AA; Levenson V; Guerra E; Simeone P; Alberti S; Deng Y
    BMC Cancer; 2015 May; 15():417. PubMed ID: 25986046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methylation of AKAP12{alpha} promoter in lung cancer.
    Jo UH; Whang YM; Sung JS; Kim YH
    Anticancer Res; 2010 Nov; 30(11):4595-600. PubMed ID: 21115911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer.
    Liu S; Chen X; Chen R; Wang J; Zhu G; Jiang J; Wang H; Duan S; Huang J
    Oncotarget; 2017 May; 8(22):36354-36367. PubMed ID: 28422739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFR.
    Ren S; Su C; Wang Z; Li J; Fan L; Li B; Li X; Zhao C; Wu C; Hou L; He Y; Gao G; Chen X; Ren J; Li A; Xu G; Zhou X; Zhou C; Schmid-Bindert G
    Int J Cancer; 2014 Dec; 135(12):2962-71. PubMed ID: 24771540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
    Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z
    Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts.
    Vizoso M; Puig M; Carmona FJ; Maqueda M; Velásquez A; Gómez A; Labernadie A; Lugo R; Gabasa M; Rigat-Brugarolas LG; Trepat X; Ramírez J; Moran S; Vidal E; Reguart N; Perera A; Esteller M; Alcaraz J
    Carcinogenesis; 2015 Dec; 36(12):1453-63. PubMed ID: 26449251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genome-wide profiles of methylation, microRNAs, and gene expression in chemoresistant breast cancer.
    He DX; Gu F; Gao F; Hao JJ; Gong D; Gu XT; Mao AQ; Jin J; Fu L; Ma X
    Sci Rep; 2016 Apr; 6():24706. PubMed ID: 27094684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer.
    Suzuki M; Shigematsu H; Iizasa T; Hiroshima K; Nakatani Y; Minna JD; Gazdar AF; Fujisawa T
    Cancer; 2006 May; 106(10):2200-7. PubMed ID: 16598760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.